Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections. (Q37995171)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

4

Ronald N Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

2

Rodrigo E Mendes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Cesar A Arias

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Matthew G Stilwell

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Barbara E Murray

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

1 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

54 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

S233-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

A CASE OF ACUTE ENDOCARDITIS CAUSED BY MICROCOCCUS ZYMOGENES (NOV. SPEC.), WITH A DESCRIPTION OF THE MICROORGANISM

26 January 2020

cites work

1 reference

12 December 2020

Activity of LY333328 combined with gentamicin in vitro and in rabbit experimental endocarditis due to vancomycin-susceptible or -resistant Enterococcus faecalis

1 reference

12 December 2020

Staphylococcus aureus endocarditis: a consequence of medical progress

1 reference

12 December 2020

Studies on antibiotic synergism against enterococci. I. Bacteriologic studies

1 reference

12 December 2020

Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.

1 reference

12 December 2020

Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy

1 reference

12 December 2020

Vancomycin and oritavancin have different modes of action in Enterococcus faecium

1 reference

12 December 2020

Intrinsic penicillin resistance in enterococci

1 reference

12 December 2020

Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection

1 reference

12 December 2020

Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding?

1 reference

12 December 2020

Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing

1 reference

12 December 2020

Impact of human serum albumin on oritavancin in vitro activity against enterococci

1 reference

12 December 2020

High-level resistance to gentamicin in clinical isolates of enterococci.

1 reference

12 December 2020

Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis

1 reference

12 December 2020

In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci

1 reference

12 December 2020

Optimizing therapy for vancomycin-resistant enterococci (VRE).

1 reference

12 December 2020

Characterizing vancomycin-resistant Enterococcus strains with various mechanisms of daptomycin resistance developed in an in vitro pharmacokinetic/pharmacodynamic model

1 reference

12 December 2020

Transition of Enterococcus faecium from commensal organism to nosocomial pathogen.

1 reference

12 December 2020

Assessment of oritavancin serum protein binding across species

1 reference

12 December 2020

Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk.

1 reference

12 December 2020

Treatment of enterococcal endocarditis and bacteremia; results of combined therapy with penicillin and streptomycin

1 reference

12 December 2020

Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans

1 reference

12 December 2020

Moderate-level resistance to glycopeptide LY333328 mediated by genes of the vanA and vanB clusters in enterococci.

1 reference

12 December 2020

Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem

1 reference

12 December 2020

Mechanism of Resistance to Antibiotic Synergism in Enterococci

1 reference

12 December 2020

Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.

1 reference

12 December 2020

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

1 reference

12 December 2020

Emergence and management of drug-resistant enterococcal infections

1 reference

12 December 2020

Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing

1 reference

12 December 2020

Mechanism of action of oritavancin and related glycopeptide antibiotics

1 reference

12 December 2020

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

1 reference

12 December 2020

Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIR924

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

22431854

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22431854%20AND%20SRC:MED&resulttype=core&format=json